Research by Gil I. Wolfe, MD, UB Distinguished Professor and Irvin and Rosemary Smith Chair of the Department of Neurology, shows that surgery to remove the thymus gland in patients with myasthenia gravis (MG) provides significant clinical benefits for as long as five years after the procedure.
Three medical students traveled to Malawi to collaborate with the local community and a branch of the organization Naturally Africa Volunteers in an effort to understand undernutrition and assist local organizations combating it.
Joshua H. Gordon, a student in the MD-PhD Program, is lead author of a study showing that postmenopausal women who have experienced loss of all teeth are at higher risk of developing high blood pressure.
Researchers in the Department of Emergency Medicine are the first to clinically assess and validate a rule regarding the length of observation time necessary before opioid overdose patients can be safely discharged from an emergency department (ED).
Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of medicine, spoke about the benefits of heart monitor apps for cardiac patients in a presentation at the 2019 Consumer Electronics Show (CES) in Las Vegas.
When he heard about the first National Physician Suicide Awareness Day, Christian R. DeFazio, MD, clinical associate professor of emergency medicine and director of the emergency medicine residency program, wasn’t sure what to make of it.
The Hepatology Clinic at Erie County Medical Center (ECMC), under the direction of Anthony D. Martinez, MD, clinical associate professor of medicine, has been awarded a New York State Department of Health Commissioner’s Special Recognition Award.
Steven J. Fliesler, PhD, SUNY Distinguished Professor and the Meyer H. Riwchun Endowed Chair Professor of ophthalmology, has been awarded a $2.2 million grant from the National Eye Institute of the National Institutes of Health to better understand a rare cause of blindness that strikes young children.
New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.